The outcome of Phase II will be to examine for a difference in HADS scores between women in Phase I who did not have the intervention and women in Phase II who were given the intervention (the prediction risk) at each time point (immediately after IPUVI diagnosis, after 72 hours and immediately before the 14-day follow-up scan).